Molecular study offers insights for possible cure of treatment resistance and new drug possibilities based upon better understanding of the GRP78-Cripto Protein. CureMatch’s Tsigelny published in current Protein Science Journal article. SAN DIEGO, CA – January 31, 2018: Igor F. Tsigelny, Ph.D., Co-founder and Chief Science Officer at CureMatch®, is a senior author of “Cripto […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.